Impact of Three to Five Rounds of Mass Drug Administration on Schistosomiasis and Soil-Transmitted Helminths in School-Aged Children in North-Central Nigeria
Overview
Authors
Affiliations
Nasarawa and Plateau states of north-central Nigeria have implemented programs to control schistosomiasis (SCH) and soil-transmitted helminths (STH) in children since the 1990s. Statewide mapping surveys were conducted in 2013, when 11,332 school-aged children were sampled from 226 schools. The local government areas (LGAs) then received varying combinations of mass drug administration (MDA) for the next 5 years. We revisited 196 (87%) schools in 2018 plus an additional six (202 schools in total), sampling 9,660 children. We calculated overall prevalence and intensity of infection and evaluated associations with gender; age; behaviors; water, sanitation, and hygiene (WASH); and treatment regimen. Urine heme detection dipsticks were used for Schistosoma hematobium in both surveys, with egg counts added in 2018. Stool samples were examined by Kato-Katz for Ascaris lumbricoides, Trichuris trichiura, Schistosoma mansoni, and hookworm. Schistosomiasis prevalence among sampled students dropped from 12.9% (95% confidence interval [CI]: 11.1-14.9%) to 9.0% (95% CI: 7.5-10.9%), a statistically significant change (P < 0.05). In 2018, eight LGAs still had > 1% of children with heavy-intensity schistosome infections. Prevalence of STH infection did not significantly change, with 10.8% (95% CI: 9.36-12.5%) of children positive in 2013 and 9.4% (95% CI: 8.0-10.9%) in 2018 (P = 0.182). Heavy-intensity STH infections were found in < 1% of children with hookworm, and none in children with A. lumbricoides or T. trichiura in either study. The WASH data were collected in 2018, indicating 43.6% of schools had a latrine and 14.4% had handwashing facilities. Although progress is evident, SCH remains a public health problem in Nasarawa and Plateau states.
Stark K, Rinaldi G, Costain A, Clare S, Tolley C, Almeida A Anim Microbiome. 2024; 6(1):36.
PMID: 38918824 PMC: 11201864. DOI: 10.1186/s42523-024-00318-3.
Akinsolu F, Abodunrin O, Olagunju M, Adewole I, Ola O, Abel C PLoS One. 2024; 19(5):e0302509.
PMID: 38718082 PMC: 11078364. DOI: 10.1371/journal.pone.0302509.
Griswold E, Eigege A, Emukah E, Pace Gallagher J, Coalson J, Rakers L Am J Trop Med Hyg. 2024; 111(3_Suppl):69-80.
PMID: 38593792 PMC: 11376119. DOI: 10.4269/ajtmh.23-0600.
Le B, Clarke N, Legrand N, Vaz Nery S Infect Dis Poverty. 2024; 13(1):16.
PMID: 38369483 PMC: 10874526. DOI: 10.1186/s40249-024-01185-5.
Wamyil-Mshelia T, Madaki S, Isiyaku S, Shuaibu J, Olobio N, Aliero A Int Health. 2023; 15(Supplement_2):ii12-ii18.
PMID: 38048379 PMC: 10695469. DOI: 10.1093/inthealth/ihad086.